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For the past few decades, the Eastern Mediterranean Region has been one area of the 
world profoundly shaped by war and political instability. On-going conflict and destruc-
tion have left the region struggling with innumerable health concerns that have claimed 
the lives of many. Wars, and the chaos they leave behind, often provide the optimal 
conditions for the growth and re-emergence of communicable diseases. In this article, 
we highlight a few of the major re-emerging vaccine preventable diseases in four coun-
tries of the Eastern Mediterranean Region that are currently affected by war leading to a 
migration crisis: Iraq, South Sudan, Syria, and Yemen. We will also describe the impact 
these infections have had on patients, societies, and national health care services. This 
article also describes the efforts, both local and international, which have been made 
to address these crises, as well as future endeavors that can be done to contain and 
control further devastation left by these diseases.
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INTRODUCTION
In 1963, Dr. T. Aidan Cockburn, in his book called The Evolution and Eradication of Infectious 
Diseases, stated that “it seems reasonable to anticipate that within some measurable time … all the 
major infections will have disappeared” (1). Cockburn was writing in an era when it was believed 
that infectious diseases would soon be a thing of the past. During the 1950s and 1960s, developing 
countries saw a tremendous increase in vaccination campaigns against polio, smallpox, measles, 
and many other common infections. However, as new and old diseases continued to emerge, it soon 
became apparent that this initial optimism was misguided (2).
A newly emerging disease is one that has not been described or identified before. Re-emerging 
infectious diseases, on the other hand, are diseases that although were once eradicated, have later 
resurfaced to pose a significant health problem once again (3). Many of these infections were eradi-
cated with the advent of effective vaccines. In fact, the world has witnessed an upward trend in the 
rates of vaccination coverage from 74% in 2000 to 85% just 10 years later (4). Despite these strides, 
in the twenty-first century, infectious diseases continue to be one of the leading causes of death in 
developing countries (5).
FIGURE 1 | Map of the Eastern Mediterranean Region. The four countries of 
interest, Iraq, South Sudan, Syria, and Yemen are depicted in red. The main 
migratory routes of refugees from these countries to neighboring countries 
are mapped with arrows.
TABLE 1 | Summary of three major re-emerging vaccine-preventable diseases in the Eastern Mediterranean Region.
Human 
disease
Infectious agent Mode of 
transmission
Symptoms Treatment Available vaccine Re-emerging 
EMR countries
Poliomyelitisa Polio virus Fecal–oral Asymptomatic, may affect the 
CNS and cause paralysis
Supportive Salk Vaccine—IPV: inactivated polio 
vaccine
Syria, Iraq
Sabin Vaccine—OPV: oral polio vaccine
Measlesb Measles virus Direct contact with 
infectious droplet or 
by airborne spread
Maculopapular rash, fever, 
cough, coryza, conjunctivitis, 
koplik spots
Supportive Either alone or as part of a combination 
(e.g., MMR, MMRV)
Iraq, South 
Sudan, Syria, 
Yemen
Cholerac Vibrio cholerae 
bacteria
Fecal–oral through 
contaminated food 
and water
Profuse watery diarrhea (“rice-
water” diarrhea), symptoms of 
dehydration
Rehydration 
therapy, 
antibiotics for 
severe illness
Two oral killed vaccines: Dukoral and 
Shanchol (Shantha Biotechnics-Sanofi 
Pasteur)
South Sudan, 
Yemen
aMehndiratta et al. (76).
bNaim (77).
cHarris et al. (78).
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There have been numerous factors attributed to disease 
re-emergence. These include microbial adaptation and change, 
increased human susceptibility to infection, changing environ-
ments, evolving human demographics and behavior, economic 
development, international travel, antimicrobial resistance, 
breakdown in public health measures, increased poverty and 
social inequality, and on-going war and famine (6). This is 
particularly true in vulnerable populations such as refugees and 
displaced peoples who are faced with innumerable obstacles in 
obtaining adequate health care.
The World Health Organization (WHO) Eastern Mediterranean 
Region (EMR) is one area of the world that is currently undergo-
ing major political and economic upheaval. Of the 22 countries 
that comprise the region, Iraq, South Sudan, Syria, and Yemen, are 
four countries currently undergoing continuous conflict leading 
to mass displacement. These countries, in addition to the migra-
tory routes undertaken by refugees to neighboring countries, 
are mapped in Figure 1. Along with the political disturbances, a 
major health crisis has been brewing for some time now with the 
rise of once-eradicated communicable diseases. It seems that a 
future without infectious diseases is a long way away.
In this review, we will highlight the delicate interplay between 
war, displacement, and the re-emergence of once eradicated 
vaccine-preventable diseases (VPDs), namely cholera, measles, 
and polio, as illustrated in Table 1. Disease re-emergence will be 
described in the context of the aforementioned countries’ politi-
cal, economic, and health care scenes. Finally, we will provide 
several recommendations on how to avert the rise of these infec-
tions, tackling various social, political, and financial barriers.
OVERVIEW OF THE RE-EMERGING 
VACCINE PREVENTABLE DISEASES
Cholera
Cholera is an acute diarrheal illness caused by ingesting water 
or food contaminated with the infectious agent, Vibrio cholerae. 
Just like other infectious diseases, cholera can easily spread in 
areas of poor sanitation with contaminated water supplies such 
as refugee camps. There have been seven cholera pandemics since 
the seventeenth century, and most outbreaks have been closely 
linked to conflict and economic crises (7). It is estimated that 2.9 
million cases and 95,000 deaths in endemic countries are annually 
attributed to cholera (8). In the EMR, 14 out of the 22 countries 
have witnessed cholera breakouts in the past decade alone (9). 
Although most people remain asymptomatic or experience mild 
symptoms, cholera can be deadly, particularly if those afflicted are 
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left without adequate hydration. While it is not routinely admin-
istered to children worldwide, the oral cholera vaccine (OCV) 
may be beneficial in endemic countries where access to proper 
health care may prove difficult (10).
Polio
Polio belongs to the Enterovirus genus of the Picornaviridae fam-
ily. The virus causes a disease that has long been known to have 
devastating effects on the children it inflicts, affecting the nerv-
ous system and causing partial or total paralysis. By the 1980s, 
polio was responsible for paralyzing more than one thousand 
children every day worldwide (11). This prompted the Global 
Polio Eradication Initiative (GPEI) to be established in 1988, 
which succeeded in immunizing more than 2.5 billion children 
against the virus and decreasing the incidence of polio worldwide 
by 99% since its inception (11). To date, the EMR has seen a total 
of 10 cases since the start of 2017, a substantial drop from the 
74 cases of 2015 (12). Despite the tremendous strides achieved 
in eradicating this disease, polio continues to pose a significant 
health problem in affected countries.
Measles
Another vaccine-preventable disease that has flourished during 
the chaos of war is measles. The etiological agent is the Measles 
virus (MeV): a member of the Paramyxoviridae family. Measles is 
a highly contagious airborne disease, which since the advent of a 
successful vaccine, has largely been eradicated in many parts of the 
world. The WHO estimates that measles alone was responsible for 
approximately 9.7 million cases and 254,928 deaths in 2016, with 
a large proportion of these fatalities occurring among children 
in developing countries (13). In 1997, all countries of the EMR 
set measles elimination as a goal to be achieved by 2010, and a 
four-plan strategy detailing vaccination activities was devised. By 
2010, the number of reported measles cases in the EMR decreased 
by 77% from 1998 (14). With war and conflict taking place in 
many of these countries, efforts to contain the disease have not 
always proved successful. Although no specific treatment exists, 
most relief efforts are aimed toward effective immunization and 
prevention.
EMR COUNTRIES WITH  
RE-EMERGING VPDs
Iraq
In the past three decades, Iraq has undergone many political 
calamities, leaving the country into a constant state of insecurity. 
In 2003, the country was thrown into political upheaval that was 
compounded with United States involvement. Although the Iraq 
War officially ended in 2011, conflict has continued to involve dif-
ferent religious and ethnic factions, contributing to a crackdown 
in social order with almost 3 million people internally displaced 
by 2017 (15). Throughout this, one aspect that has suffered tre-
mendously is the Iraqi health care system.
Prior to the eruption of the Gulf Wars in the 1980s, Iraq 
provided free health care to its people in 172 hospitals and 1,200 
primary health care centers located throughout the country (16). 
Since then, continuous political and economic instability has 
left the country with a health care infrastructure that is unable 
to meet even the most basic health needs of its people. A study 
performed in Iraq revealed that in 2011, there were only 7.5 phy-
sicians for every 10,000 citizens, which is almost half the global 
ratio of 14/10,000 (17). Another measure of this deterioration is 
a decline in health indicators, such as life expectancy at birth, 
which in 2010 was 58 years, a decrease from 65 years in 1980 (18).
In 2000, about 61% of Iraqi children were fully vaccinated 
(19). Just 1 year after the start of the war in 2004, Iraq witnessed 
a tremendous surge in the rates of vaccine-preventable diseases. 
In the first few months after the US invasion, numerous primary 
health care centers and hospitals were destroyed, vaccinations 
became short in supply, and access to unvaccinated people in 
remote areas became difficult.
During the 1980s, polio immunization was mandatory in the 
country. In the 1990s and until 2003, national polio vaccination 
campaigns were held annually, and vaccination rates reached 
those similar to the pre-Gulf War era (19). After 14 years of being 
polio free, in 2013 the country confirmed its first case of polio in 
an unvaccinated infant living on the outskirts of Baghdad (20). 
This was most likely linked to the re-emergence of the virus in 
neighboring, war-torn Syria. Despite this, and several other cases, 
since April 2014 there have been no new cases of polio in the 
country, and Iraq was removed from the list of polio-infected 
countries in March of the following year (21). In the spring of 
2016, a 5-day polio vaccination campaign was set out to vaccinate 
more than 5 million children under the age of five. The campaign, 
which was brought about by the Iraqi Ministry of Health, with 
support from the WHO and UNICEF aimed at preventing a 
resurgence of the disease (21).
In the early 1980s, Iraq adopted the WHO Expanded Program 
on Immunization (EPI) leading to a decrease in the annual 
number of measles cases from 39,000 to 9,400 (22). The coun-
try’s immunization schedule included two doses of the measles 
containing vaccine (MCV1 and MCV2). However, with the 
advent of political instability in the region, the number increased 
nearly twofold by 2013 (14). In the first half of 2004, there were 
8,253 cases of measles reported in Iraq, which was a significant 
increase from the 454 cases described in 2003 (23). Vaccination 
rates plummeted from 87% in 2000 to 69% in 2009. By early 2014, 
around 1,040 cases had been described in the country, prompting 
a nation-wide vaccination campaign (24).
Adequate vaccination is crucial to achieve herd immunity 
and prevent the occurrence of outbreaks. A study conducted in 
2012 showed that even those who had received one dose of the 
MCV vaccine had a 3.7 times lower risk of contracting measles 
compared to those who had never received it (25). Some of the 
obstacles impeding the progress of nation-wide vaccination 
campaigns include mass displacement and migration, inefficient 
vaccination initiatives, inadequate surveillance, and lack of 
funds (14).
South Sudan
After decades of civil war in Sudan, South Sudan finally seceded 
and declared its independence in 2011, making it the world’s 
youngest nation. Although the separation was followed by a 
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period of peace, by 2013 civil unrest resurfaced among different 
ethnic and political factions, eventually leading to one of the 
worst refugee crises of the modern world. By 2017, of the nearly 
13 million South Sudanese citizens, almost 2 million people have 
been internally displaced, and with another 1.4 million refugees 
in neighboring countries, mainly Uganda and Ethiopia (26). 
In addition to on-going violence and civil unrest, the citizens of 
South Sudan have been subject to rising poverty, malnutrition, 
and unpredictable natural disasters (27).
Prior to the eruption of war, Sudan employed a government-
run Public Health System that was the only provider of health 
services. After 2011, a three-layered health system structure 
was adopted consisting of Primary Health Care Units (PHCU), 
Primary Health Care Centers (PHCC), and hospitals (28). 
In 2006, following a period of peace in the country, the Government 
of Southern Sudan formulated the “Basic Package of Health 
and Nutrition Services” that detailed a plan for immunization 
program development. The EPI then prepared the “2007–2011 
Comprehensive Multi-Year Plan (cMYP) for Immunization” to 
be used until the country gained independence (29, 30), with a 
follow-up program designed after few years.
With the rising refugee and migration crisis in the country, 
the health care system has suffered major setbacks. Currently, the 
country has one of the worst health indicators worldwide, with 
life expectancy at the age of 54 years. The health care system is 
also suffering from a severe shortage of health professionals with 
one physician for every 65,574 people (31). Despite the many free 
services offered by the Public Healthcare System, the majority 
of the population live in impoverished, remote areas with little 
access to health care facilities (32, 33). This, paired with a govern-
ment that in 2014 spent only 2.7% of the country’s GDP on health 
care, has only served to worsen the problem (34).
One recent survey found that the percentage of fully immu-
nized children was only 7.3%, with the percentage of partially 
immunized children not much higher (35). In 2000, the EPI 
estimated that measles vaccination coverage was about 63% in the 
country (36). Although Southern Sudan had endured multiple 
measles outbreaks in recent decades, with the most notable one 
occurring in October 2003 (37), by the spring of 2015, the country 
had witnessed one of the worst measles outbreaks of the region, 
with a total of 1,730 confirmed cases and 22 deaths. By May 2017, 
664 suspected cases and three fatalities were reported (38). This 
prompted the Ministry of Health, in partnership with UNICEF, to 
launch a massive vaccination campaign to immunize 7.9 million 
children between the ages of 6 months and 15 years (39).
Another disease that has flourished in South Sudan in recent 
years is cholera. Although endemic to the country, a devastat-
ing outbreak of the disease has claimed the lives of 320 people 
and afflicted 17,785 others since June 2016 (40). When it first 
appeared in 2014, the South Sudanese Ministry of Health, in 
partnership with WHO, carried out a mass cholera vaccination 
campaign between February and April 2014, which succeeded 
in immunizing 60–85% of the target population. A retrospective 
study found that those who had received two doses of the vaccine 
were 4.5 times less likely to develop severe disease compared to 
their unimmunized counterparts (41). However, with a popula-
tion on the brink of starvation, and often fleeing from areas of 
conflict, cholera continues to be a deadly disease. By 2015, the 
global stockpile of the cholera vaccine contained only 900,000 
vaccines, making its allocation to the 1 million people at risk an 
even more difficult task (42).
Despite their successes, vaccination campaigns are not suffi-
cient to solve the growing problem. Access to health care services 
is often impeded and the presence of refugees and displaced people 
in rural areas, away from major cities serves only to compound 
the problem. In addition, an on-going famine in the country has 
left almost a million people on the brink of starvation, leaving 
those inflicted immunocompromised and unable to fight off an 
otherwise mild infection (43).
Similarly, the chaos created by wars and conflict make proper 
surveillance and monitoring systems of vaccination programs 
a difficult, yet necessary task. In June 2017, the South Sudanese 
government announced the death of 15 children due to contami-
nated measles vaccines (44). Inadequate storage, including lack of 
refrigeration, and poor administration practices, such as reusing 
syringes, were cited as some of the reasons for this incident. 
Any efforts aimed at containing the rise of vaccine preventable 
diseases in South Sudan needs to tackle the staggering number of 
health concerns from all aspects.
Syria
During the 1960s, Syria underwent major political upheaval 
with the establishment of a socialist government. Despite the 
political reforms, the country enjoyed relative economic stability, 
which reflected well on the health care system. During that time, 
health care primarily consisted of a government-run system that 
provided citizens with access to nationwide primary health care 
services (45). Political stability was accompanied by an improve-
ment in overall life expectancy, which rose from 56 years in 1970 
to 73.1 years in 2009, and infant mortality decreased from 132 
deaths for every 1,000 live births in 1970 to 17.9 per 1,000 in 
2009 (46). The country also boasted of a thriving pharmaceutical 
industry; one that was able to cover almost 90% of the countries 
national needs, in terms of both local use and international 
export (47).
Since 2011, the country has been at the center of a political 
crisis that has taken the world by storm. More than 5 years after 
the start of the Syrian Civil War, the world has witnessed one of 
the worst refugee crises seen since WWII (48). A recent WHO 
survey updated in February 2017 revealed that more than 7.5 
million people are displaced within Syria and almost 5 million 
have fled to neighboring countries such as Lebanon, Jordan, and 
Turkey (49).
Other than the direct casualties of war, the Syrian crisis has 
claimed many victims from basic health care issues that otherwise 
could have been prevented. Hospitals and ambulances were the 
frequent targets of missiles and explosions, leading to a crumbling 
of any health care infrastructure previously present. More than 
700 medical workers have been killed since the start of the war in 
2011 and more than 60 health care facilities have been destroyed in 
the past year alone (50). Internally displaced people and refugees 
who have moved to neighboring countries are forced to reside in 
poor living conditions, with limited access to sanitation and basic 
health care services. Diseases such as measles and polio, that were 
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once thought eradicated, now found the perfect breeding ground 
to thrive and spread.
In Syria, prior to the outbreak of the war, the last documented 
case of polio was reported in 1999. The lack of proper immuni-
zation, coupled with contaminated living conditions, led to the 
re-emergence of polio after many years of obscurity, with the first 
case documented in October 2013, and eventually reaching 35 
cases within the same year (51). The wild-type poliovirus (WPV1) 
discovered in Syria in the midst of the war is similar to the strain 
of poliovirus in Pakistan, one of the few countries in the world 
where polio remains endemic (51). It is believed that the virus 
found its way to the country by way of Pakistani freedom fighters 
(52). Prior to the conflict, an estimated 91% of Syrian children 
had been vaccinated against polio, with that number dropping to 
68% in 2012 (51). After decades of eradication, polio once again 
became a health concern to the Syrian people.
By 2014, the WHO announced that polio had become a Public 
Health Emergency of International Concern (53). These develop-
ments led the GPEI to put forth a multi-country strategy in the 
region aimed at curbing the spread of the disease. By April 2014, 
30 supplementary immunization activities (SIAs) succeeded in 
reaching more than 25 million children under the age of 5 in 
war-torn countries like Syria and Iraq, and neighboring countries 
hosting refugees, such as Jordan and Lebanon (54). This initiative, 
along with other vaccination campaigns by organizations such 
as the WHO, has led to a 3-year polio-free period in Syria since 
2014 (55). To ensure that recurrence does not happen, the WHO 
undertook a successful national polio campaign in most Syrian 
governorates for 5 days in October 2016 reaching a target of 2.8 
million children under the age of 5, 83% of the target population 
(56). These successful efforts were recognized in the 2015 Annual 
Report of the Polio Global Eradication Initiative that stated that 
the world is the closest it has ever been to being polio free (57).
Factors that may jeopardize this success include continued 
conflict, inability to reach besieged areas, and the rapidity by 
which the disease can spread in poor living conditions. Continued 
efforts need to be made by both international and local groups 
to ensure continued immunizations against devastating diseases 
such as polio. In 2010, a case of polio reported in the Republic 
of Congo revealed a mutated virus in a previously immunized 
individual. While there have been no reports in Syria of mutated 
polio virus infections in vaccinated individuals, it is imperative to 
keep in mind that effective eradication of the disease will need to 
take into account possible antigenetic variants that can continue 
to persist despite adequate vaccination measures (58).
Yemen
In March 2015, Yemen underwent major political upheaval when 
war broke out between different religious factions. Since then, 
thousands have been killed and many more have been displaced. 
Yemen, which had a fragile health care system prior to the onset 
of war, did not have the infrastructure to withstand these changes 
and is currently on the brink of collapse. Prior to the war, Yemen 
had one of the highest rates of childhood malnutrition worldwide 
(59). In the past 2 years, continuous airstrikes have led to the 
destruction of health care facilities and have made access to the 
ones standing difficult for those in need. Similar to the situation 
in Iraq, South Sudan, and Syria, vaccine-preventable diseases saw 
a sudden surge after the beginning of the crisis (60).
Prior to the war, Yemen had a relatively stable vaccination rate 
reaching 70–80% of the target population (61). By November 
2015, measles vaccination dropped to 54% from 75% of the 
previous year (62). By April 2016, a large house-to-house vac-
cination campaign undertaken by the Ministry of Public Health 
and Population in collaboration with the WHO and UNICEF 
managed to successfully vaccinate more than 90% of targeted 
children (63). To ensure its continued success, further vaccina-
tion campaigns will need to be undertaken in the near future.
On October 6, 2016, health authorities in Yemen announced 
an outbreak of cholera. By the end of December of the same year, 
there had been 163 confirmed cases, with 96 associated deaths 
(64). By June 2017, the United Nations announced that country 
is currently facing the “worst cholera outbreak in the world” (65), 
and on August 13th of the same year, the total number of sus-
pected cholera cases reached half a million (66). In June 2017, the 
International Coordinating Group (ICG) on vaccine provision 
announced a plan to send half of the global stockpile of cholera 
vaccine to Yemen in an effort to curb the rise of this devastating 
infection (67). A month later, the WHO sent hundreds of tons 
of aid including medical supplies. Other relief organizations, 
such as the Red Cross and the European Commission, have also 
contributed similarly (67).
Vulnerable groups include children and the elderly, in addition 
to immunosuppressed people and those with multiple comorbidi-
ties. A failing sewage system, continued conflict and inadequate 
health care facilities are only a few of the reasons contributing to 
this problem. Malnutrition, which is a significant consequence of 
the Yemen War, has further contributed to this outbreak. Without 
adequate assistance from both local and international relief agen-
cies, cholera is expected to claim many more lives.
RECOMMENDATIONS FOR THE FUTURE
In 2013, the WHO developed a document titled “Vaccination 
in acute humanitarian emergencies: a framework for decision 
making” aimed at helping aid agencies and policy makers with a 
systematic method of vaccinating in times of humanitarian crises, 
that is developed to take epidemiological and contextual factors 
into account (68). The WHO and various United Nations agen-
cies have already undergone successful vaccination campaigns 
in warring countries of the EMR, and in neighboring countries 
hosting refugees. Since the implementation of vaccination cam-
paigns during active warfare is dangerous for all those involved, 
National Immunization Days (NID) have long been used as a way 
of negotiating truces or ceasefires. To ensure continued success, 
follow-up campaigns are needed, particularly for diseases that 
require booster immunizations. In cases of refugees living in 
nearby countries, it is essential to work with local governments 
and organizations to ensure concerted efforts of immunization. 
Vaccination efforts should include reaching remote regions, and 
not just people located in major cities.
Adequate monitoring of vaccination, through the use of EPI 
cards and other validated recall methods, is crucial to ensure 
adequate surveillance of vaccination rates and coverage (69). 
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Appropriate transportation and storage of vaccines, particularly 
in difficult-to-access regions, are also needed to ensure continued 
adequate coverage. Similarly, in order to prevent another short-
age of vaccines, such as the one seen in South Sudan in 2015, 
the global stockpile needs to be fully equipped and capable of 
providing vaccines quickly during emergency situations and to 
large numbers of people (42).
Delayed identification and treatment contribute to the spread 
of infectious diseases, making them even harder to control. Health 
care volunteers may unknowingly become carriers of diseases and 
transmit them back to their home countries. With globalization 
and the advent of international travel, diseases that were once 
restricted to a particular community now threaten to inflict com-
munities worldwide (70). Speedy and accurate diagnosis is also 
needed to mobilize relief activities quickly and effectively.
While immediate medical attention is in dire need, there is a 
need to re-focus efforts toward long-term public health measures 
that are likely to benefit people for years to come. Post-conflict 
Needs Assessments (PCNAs), which are multilateral exercises 
needed to evaluate the health care services in affected areas, 
should be undertaken by international organizations in collabo-
ration with national governments (71). Financial strains in the 
form of operational costs are another barrier impeding adequate 
health care, and relief organizations and foreign money are not a 
sustainable solution for the long run (72).
Many health facilities in the aforementioned countries have 
been destroyed by conflict, and the lack of the electricity and run-
ning water makes the operation of any health care infrastructure 
difficult to achieve. Security concerns prevent volunteer workers 
and patients from venturing out of safe zones in search of health 
services. Wars also often drive highly educated professionals such 
as nurses and doctors to flee, leaving the country with a short-
age of medical workers that are unable to shoulder the burden 
of a large, ailing population. Medical equipment and facilities 
are as scarce as those that operate them. Any future talks about 
re-building these countries’ health care systems need to include 
sustainable investments in infrastructure.
In addition to infrastructure, it is important that health care 
providers choose appropriate methods for approaching those in 
need of medical care. For example, refugees have been shown 
to be less likely than others to seek health care. The costs of 
vaccination were cited as a major barrier for seeking health 
care among Syrian refugees in Jordan (73). Also, language bar-
riers, discrimination and legal obstacles may deter some from 
reaching out to health care facilities (74). Adjusting to a new 
culture, compounded with increased stress and anxiety have also 
been cited as some reasons that refugees avoid seeking health 
care (75). Public education campaigns, using the appropriate 
languages and dialects, are also needed to motivate people to 
seek immunization.
CONCLUSION
Polio, measles, and cholera are but a few of the re-emerging 
vaccine preventable diseases that continue to pose a significant 
health burden in developing countries and in regions of political 
instability. While reports of war tend to focus on the casualties 
caused by airstrikes and ammunition, the long-term health 
consequences caused by inadequate prevention and treatment of 
communicable diseases are often ignored. War-affected countries 
rely on the efforts of the international community to recognize 
that the re-emergence of vaccine-preventable diseases is a global 
threat that requires a multinational approach. Until the political 
situations are resolved in these war-torn countries, infectious dis-
eases will continue to spread and inflict vulnerable populations. 
We are now more than a decade into the twenty-first century, and 
re-emerging infectious diseases in times of war continue to pose 
a real and frightening threat to mankind.
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